— Know what they know.
Not Investment Advice

IRMD NASDAQ

IRadimed Corporation
1W: -3.5% 1M: -1.3% 3M: -10.8% YTD: -11.2% 1Y: +9.4% 3Y: +123.8% 5Y: +151.7%
$83.95
-0.68 (-0.80%)
After Hours: $85.92 (+1.97, +2.35%)
Weekly Expected Move ±2.5%
$81 $84 $86 $88 $90
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 48 · $1.1B mcap · 8M float · 1.49% daily turnover · Short 33% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z 52.34.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

📊 Key Metrics

TTM
$86M
Revenue
+11.2% YoY
$23M
Net Income
+11.6% YoY
$25M
Free Cash Flow
+84.0% YoY
74.1%
Gross Margin
31.2%
Op. Margin
25.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE23.5%
ROA20.8%
ROIC50.1%

Valuation

P/E46.0
P/B10.5
EV/EBITDA37.6

Leverage

Debt/Equity0.00
Current Ratio9.46
Interest Cov.0.0x

Quality Scores

Piotroski F6/9
Altman Z59.05
Beneish M-2.56

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms